View More Recent Stories

Sep 17, 2024 04:10PM Jones Trading Starts Intellia Therapeutics (NTLA) at Buy
Aug 9, 2024 06:27AM Intellia Therapeutics (NTLA) PT Lowered to $54 at RBC Capital
Aug 8, 2024 07:30AM Intellia Therapeutics (NTLA) Misses Q2 EPS by 30c
Jun 26, 2024 08:55AM BMO Capital Reiterates Outperform Rating on Intellia Therapeutics (NTLA)
Jun 26, 2024 07:30AM Intellia Therapeutics (NTLA) Announces CFO Transition
Jun 26, 2024 05:27AM Brookline Capital Markets Reiterates Buy Rating on Intellia Therapeutics (NTLA)
Jun 25, 2024 03:30PM Intellia Therapeutics (NTLA) Announces Positive Clinical Proof-of-Concept Data for Redosing a CRISPR-Based Therapy with its Proprietary LNP-Based Delivery Platform
Jun 24, 2024 12:15PM Stifel on Intellia Therapeutics (NTLA): 'Positive Ph.3 HELIOS-B data this morning validates the NTLA-2001 approach'
Jun 24, 2024 10:32AM Truist Securities Reiterates Buy Rating on Intellia Therapeutics (NTLA)
Jun 24, 2024 09:49AM Baird on Intellia Therapeutics (NTLA): 'we anticipate enthusiasm will wane'
Jun 24, 2024 07:58AM Alnylam (ALNY) data is positive for Ionis (IONS), Intellia (NTLA) and negative for BridgeBio (BBIO) - analyst
Jun 14, 2024 07:30AM Intellia Therapeutics (NTLA) Appoints Brian Goff to its Board
Jun 10, 2024 05:38AM RBC Capital Reiterates Outperform Rating on Intellia Therapeutics (NTLA)
View More Recent Stories